IsomiR processing during differentiation of myelogenous leukemic cell line K562 by phorbol ester PMA

Gene ◽  
2018 ◽  
Vol 641 ◽  
pp. 172-179 ◽  
Author(s):  
Pamchui Muiwo ◽  
Priyatama Pandey ◽  
Hafiz M. Ahmad ◽  
Suganthi S. Ramachandran ◽  
Alok Bhattacharya
1984 ◽  
Vol 99 (1) ◽  
pp. 340-343 ◽  
Author(s):  
J M Besterman ◽  
P Cuatrecasas

The human, leukemic cell line, HL-60, undergoes differentiation in response to tumor-promoting phorbol esters. Recent studies have implicated stimulation of a Na+/H+ antiporter as an initial event in cellular differentiation and/or proliferation. The effects of phorbol esters on Na+-dependent H+ efflux from HL-60 cells were studied by pH-stat titration. Tumor-promoting phorbol diesters, but not the inactive parent alcohol, stimulated Na+-dependent H+ efflux in a rapid (within 1 min at 37 degrees C) and reversible manner. Stimulation was dependent on the concentration of extracellular sodium; lithium could substitute for sodium, but choline could not. Stimulation was dependent on the activity of extracellular protons and was inhibited completely by amiloride. The concentrations of phorbol diesters at which we observed half-maximal stimulation of Na+-dependent H+ efflux are very similar to the Kd reported in the literature for binding of these phorbol diesters to the phorbol ester receptor and the Km for phorbol diester activation of protein kinase C. Overall characterization of basal and phorbol ester-stimulated H+ efflux indicate that stimulation of a Na+/H+ antiporter constitutes a primary event in phorbol ester interaction with HL-60 cells.


1997 ◽  
Vol 235 (1) ◽  
pp. 35-47 ◽  
Author(s):  
Sylvette Ayala-Torres ◽  
Peter C. Moller ◽  
Betty H. Johnson ◽  
E.Brad Thompson

Blood ◽  
1991 ◽  
Vol 78 (2) ◽  
pp. 524-532 ◽  
Author(s):  
RA Zeff ◽  
YF Zhao ◽  
R Tatake ◽  
H Lachman ◽  
F Borriello ◽  
...  

Abstract Numerous tumor cell lines of leukemic origin are known to modulate cell surface expression of major histocompatibility complex (MHC) class I antigens resulting in alterations in their immune detection and tumorigenicity. We have been studying the mechanisms responsible for attenuation of MHC class I gene expression in an H-2 heterozygous (H-2b x H-2d) Abelson-Murine leukemia virus (A-MuLV)-transformed leukemic cell line (designated R8). Here we report that treatment of the R8 cell line with the protein synthesis inhibitor cycloheximide (CHX) increased H-2Kb steady-state messenger RNA (mRNA) levels several fold. The induced H-2Kb mRNA transcripts were functional, as demonstrated by their ability to be translated into immunoprecipitable H-2Kb alloantigen. H-2Kb null variants derived from the R8 cell line were shown to be the product of both cis- and trans-acting mechanisms, insomuch as the treatment of R8-derived H-2Kb non-expressor lines with CHX re-established expression of H-2Kb mRNA to the same extent as transfection of the variant cell line with the wild-type H-2Kb gene. Such findings indicate that downregulation of MHC class I gene expression is constitutive for the R8 leukemic cell line, a phenomenon that may be related to the immature pre-B-cell phenotype of this A-MuLV transformant.


PLoS ONE ◽  
2013 ◽  
Vol 8 (12) ◽  
pp. e85046 ◽  
Author(s):  
Lakshna Mahajan ◽  
Hrishikesh Pandit ◽  
Taruna Madan ◽  
Poonam Gautam ◽  
Ajit K. Yadav ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document